AU2000272704A1 - Use of compounds for the treatment of obesity - Google Patents

Use of compounds for the treatment of obesity

Info

Publication number
AU2000272704A1
AU2000272704A1 AU2000272704A AU7270400A AU2000272704A1 AU 2000272704 A1 AU2000272704 A1 AU 2000272704A1 AU 2000272704 A AU2000272704 A AU 2000272704A AU 7270400 A AU7270400 A AU 7270400A AU 2000272704 A1 AU2000272704 A1 AU 2000272704A1
Authority
AU
Australia
Prior art keywords
obesity
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000272704A
Inventor
Edward Leon Barsoumian
Harrie C. M. Boonen
Nanni Din
Christian Fledelius
Erik Bardrum Nielsen
Seiichiro Nishimura
Kirsten Raun
Carsten Enggaard Stidsen
Soren Tullin
Heike A. Wieland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Novo Nordisk AS
Original Assignee
Boehringer Ingelheim International GmbH
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH, Novo Nordisk AS filed Critical Boehringer Ingelheim International GmbH
Publication of AU2000272704A1 publication Critical patent/AU2000272704A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
AU2000272704A 2000-09-15 2000-09-15 Use of compounds for the treatment of obesity Abandoned AU2000272704A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2000/000514 WO2002022122A1 (en) 2000-09-15 2000-09-15 Use of compounds for the treatment of obesity

Publications (1)

Publication Number Publication Date
AU2000272704A1 true AU2000272704A1 (en) 2002-03-26

Family

ID=8149401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000272704A Abandoned AU2000272704A1 (en) 2000-09-15 2000-09-15 Use of compounds for the treatment of obesity

Country Status (2)

Country Link
AU (1) AU2000272704A1 (en)
WO (1) WO2002022122A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003065036A1 (en) * 2002-01-28 2003-08-07 Karolinska Innovations Ab Method of identifying insulin secretion stimulating compounds, and the use of such compounds in treating insulin-secretion related disorders
US8664251B1 (en) * 2009-02-26 2014-03-04 The Regents Of The University Of California Ryanodine receptor inhibitors for treatment of T-cell mediated disorders
US8937055B2 (en) 2010-07-15 2015-01-20 Takeda Pharmaceutical Company Limited Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018499A1 (en) * 1991-04-18 1992-10-29 Indiana University Foundation Novel ester derivatives of ryanodine and dehydroryanodine
IT1254216B (en) * 1992-02-25 1995-09-14 Opocrin Spa POLYSACCHARIDIC DERIVATIVES OF HEPARIN, EPARAN SULPHATE, THEIR FRACTIONS AND FRAGMENTS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5496831A (en) * 1994-05-13 1996-03-05 The General Hospital Corporation Inhibition of insulin-induced adiposis
ATE273996T1 (en) * 1997-09-12 2004-09-15 Pharis Biotec Gmbh COMPOSITION FOR THE THERAPY OF DIABETES MELLITUS AND OBESITY
AU2003999A (en) * 1997-12-19 1999-07-12 Advanced Research And Technology Institute, Inc. Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof

Also Published As

Publication number Publication date
WO2002022122A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU2935200A (en) Compounds for the treatment of obesity
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2002222853A1 (en) Therapeutic compounds
AU2002223827A1 (en) Well treatment
AU2001242450A1 (en) Substances for the treatment of spinal muscular atrophy
AU2001272852A1 (en) Composition for the treatment of migraine
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2001292480A1 (en) Novel pyridazine compounds for the treatment of diabetes
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002217866A1 (en) Geldanamycin derivatives useful for the treatment of cancer
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
AU2001293891A1 (en) New combination for the treatment of asthma
AU2002353739A1 (en) Therapeutic compounds
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002236781A1 (en) Treatment for snoring
EP1461030A4 (en) Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
AU7750100A (en) Method for the treatment of obesity
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU2002304883A1 (en) Device for the treatment of tumours
AU2000272704A1 (en) Use of compounds for the treatment of obesity